SNY News and Press, Sanofi From 03/31/24

2024-03-31 21:35:02 ET More on Regeneron, Sanofi Regeneron's Triple Threat: Eylea, Libtayo, And Dupixent Dominate Sanofi: My Top Pick In Big Pharma Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners Global Biopharma Conference (Transcript) U.S. CDC warns...

2024-03-30 10:50:43 ET More on GSK, Pfizer, etc. Sanofi: My Top Pick In Big Pharma Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference (Transcript) Pfizer, Astellas f...

2024-03-27 07:03:30 ET Beyfortus (nirsevimab), a single-dose monoclonal antibody developed and commercialized in partnership by AstraZeneca ( NASDAQ: AZN ) and Sanofi ( NASDAQ: SNY ), has been approved in Japan for the prevention of lower respiratory tract disease (LRTD) cau...

2024-03-25 13:47:00 ET Summary Boeing's top boss Dave Calhoun plans to step down at the end of the year. Mizuho turns cautious on the EV sector, downgrades Tesla, Rivian, and Nio. Look beyond the Magnificent 7 to the GRANOLAS in Europe - Goldman Sachs. Listen below o...

2024-03-25 02:07:51 ET Summary Sanofi has underperformed the U.S. stock market lately but now offers one of the smartest growth-at-a-reasonable-price setups in Big Pharma. Sanofi is best known for its patented drug Dupixent and numerous vaccines manufactured for global use, which ...

2024-03-24 13:38:10 ET More on the GRANOLAS Sequoia Fund -  SAP SE: We See A Clear Path To Enhanced Profitability ASML: Don't Be Fooled Into Buying Its Overvalued Shares Now What AstraZeneca Is Getting Through The Acquisition Of Fusion Pharmaceuticals Mo...

2024-03-20 05:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-18 12:17:28 ET More on AstraZeneca 5 Reasons AstraZeneca Stock Can Rise In 2024 AstraZeneca PLC (AZN) Q4 2023 Earnings Call Transcript AstraZeneca FY23 Earnings Review: It's OK To Buy Dip On Q4 Bottom Line Miss AstraZeneca to expand rare disease pipel...

2024-03-15 13:03:38 ET More on Sanofi Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference (Transcript) Sanofi (SNY) Leerink Partners Global Biopharma Conference (Transcript) Sanofi (SNY) TD Cowen 44th Annual Health Care Conference (Transcript) FDA ...

2024-03-13 10:25:19 ET Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference March 13, 2024 08:00 AM ET Company Participants Naimish Patel - Global Head of Development for Immunology and Inflammation Shaju Backer - Global Head of Immunology Franchise C...